Fierce Health Payers September 14, 2020
Brad Payne, PCI Pharma Services

During the coronavirus pandemic, many of us adjusted to the new “normal.” At PCI Pharma Services, we were already in the process of a digital transformation, and the COVID-19 crisis served as an opportunity to accelerate what we had started.

We are looking at the new ways of doing business—digitally and otherwise—and asking ourselves, what changes should we keep for the long term? How can we continue to provide outstanding service to our clients, based on what we have learned?

Shortening the distance

The supply chain over the last 10 years has become more global. During the pandemic, we needed to bring more of this work back to North America to simplify transportation and logistics requirements. Shortening the distance...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma, Pharma / Biotech, Public Health / COVID, Supply Chain, Technology
Amazon Business helps evolve the traditional supply chain
HHS floats hospital pay incentives to strengthen drug supply
AstraZeneca plans independent drug supply chains for US and China, CEO says
Vitality in the Supply Chain: The Limitless Potential of ATMPs
Red Sea Shipping Disruptions Don’t Have Pharma Companies Seeing Red Just Yet

Share This Article